Prof Carolyn Lam (National Heart Center, SG) & Prof John McMurray (University of Glasgow, UK) discuss the latest updates on CVOT data for Type 2 DM therapies.

Filmed by Radcliffe Cardiology on site at AHA 2018.

This peer-to-peer discussion was funded by an unrestricted grant by Novo Nordisk.